Intracellular growth of Mycobacterium avium subspecies and global transcriptional responses in human macrophages after infection by Angelika Agdestein et al.
Agdestein et al. BMC Genomics 2014, 15:58
http://www.biomedcentral.com/1471-2164/15/58RESEARCH ARTICLE Open AccessIntracellular growth of Mycobacterium avium
subspecies and global transcriptional responses
in human macrophages after infection
Angelika Agdestein1, Anya Jones2, Arnar Flatberg3, Tone B Johansen1, Inger Austrheim Heffernan1, Berit Djønne1,
Anthony Bosco2 and Ingrid Olsen1*Abstract
Background: Mycobacterium avium subsp. avium (Maa) and M. avium subsp. hominissuis (Mah) are environmental
mycobacteria and significant opportunistic pathogens. Mycobacterium avium infections in humans and pigs are
mainly due to Mah. It is not known whether this is caused by a difference in virulence or difference in exposure to
the two subspecies. The aim of the present study was to investigate the ability of the M. avium subspecies to
replicate intracellularly and to characterise the gene expression program triggered by infection of human primary
macrophages.
Results: All isolates were able to invade and persist within human macrophages. However, intracellular replication
was only evident in cells infected with the two Maa isolates. Transcriptional responses to the isolates were characterized
by upregulation of genes involved in apoptosis, immune- and inflammatory response, signal transduction and NF-kB
signaling, cell proliferation and T-cell activation. Although similar pathways and networks were perturbed by the different
isolates, the response to the Maa subspecies was exaggerated, and there was evidence of increased activation of type I
and II interferon signaling pathways.
Conclusion: Mycobacterium avium isolates of different genetic characteristics invaded monocytes and induced different
degree of macrophage activation. Isolates of Maa were able to replicate intracellularly suggesting that differences in
exposure, uptake or induction of adaptive immunity are more likely explanations for the difference in prevalence between
M. avium subspecies.
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The Mycobacterium avium complex comprises a group
of environmental and opportunistic intracellular patho-
gens [1] with the ability to persist within macrophages
and escaping the host’s killing mechanisms [2]. The
complex is constituted by the subspecies of M. avium
together with M. intracellulare [3]. Two subspecies of
clinical importance for humans and animals are M.
avium subsp. hominissuis (Mah) and M. avium subsp.
avium (Maa) [4]. Mah is the subspecies mainly isolated
from porcine and human cases of MAC infection [4],
while Maa is the causative agent of avian tuberculosis,* Correspondence: ingrid.olsen@vetinst.no
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reproduction in any medium, provided the orbut is occasionally responsible for M. avium infections in
mammals [5]. Little is known about the routes of trans-
mission and the virulence mechanisms of M. avium, and a
zoonotic potential has not been ruled out [6].
Definite reasons for Mah being the dominating sub-
species in humans and pigs infected with M. avium have
not been identified, although differences in exposure
could be considered a contributing factor. Explanations
to the higher prevalence of Mah in the human and
porcine population might also be found in differences
between Mah and Maa at the molecular level of inter-
action between the host and mycobacterium, a process
crucial to the outcome of infection, which therefore
might affect the prevalence of the subspecies. However,tral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Characteristics of Mycobacterium avium isolates
used in the present study
Isolate Subspecies Origin Biofilm ISMpa1 nsGPL ssGPL
VI101 Hominissuis Porcine + - + -
1655 Hominissuis Porcine - + - -
H1 Hominissuis Human - - + -
H38 Hominissuis Human - - + +
1553 Avium Avian - - + +
1794 Avium Avian - - + +
Isolates of Mycobacterium avium used in the present study show different
combinations of subspecies designation, origin, biofilm abilities and the genomic
presence of ISMpa1 and genes involved in the synthesis of non-specific (ns) or
serovar specific (ss) GPLs [12].
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Maa interact differently with their target cells.
Mycobacterial virulence depends on the ability of these
bacteria to invade, persist and replicate within the hostile
environment in macrophages of the host organism [7].
This is achieved by the protective properties of the my-
cobacterial cell wall and by interference with the host’s
immune response [8,9]. To assess the ability of Mah and
Maa to grow intracellularly, the use of primary cells will
give a more representative result compared to immorta-
lised macrophage cell-lines. Tissue resident macrophages
represent a heterogeneous population and it is not clear
whether M. avium infect a particular phenotype. Mono-
cyte derived macrophages matured in absence of any stim-
uli give rise to a mixed culture of both the M1 and M2
phenotype [10] and such cultures may thus be considered
appropriate for infection studies with M. avium. Finally,
using macrophages derived from the relevant target spe-
cies is important since the global inflammatory response
evoked in mice recently was demonstrated to be vastly
different from humans [11]. To the authors’ best know-
ledge, comparative studies of the ability of Maa and Mah
to invade, replicate and trigger immune responses in
human primary macrophages have not been published.
The aim of the present study was therefore to assess the
growth of M. avium isolates in human primary macro-
phages and to characterise the response triggered in in-
fected macrophages by selected isolates. The isolates used
in the present study represented the two different subspe-
cies, were derived from different host species and differed
in biofilm abilities, glycopeptidolipid (GPL) genes, and
in the presence of the insertion sequence (IS) element
ISMpa1 [12]. The present data showed that Maa repli-
cated to a larger extent in human macrophages suggesting
that an inability to grow intracellularly is not likely the
cause of the discrepancy of the prevalence of the two sub-
species in humans. Furthermore, the response induced in




Four clinical isolates of M. avium subsp. hominissuis
(Mah VI101, Mah 1655, Mah H1 and Mah H38) and
two clinical isolates of M. avium subsp. avium (Maa
1794 and Maa 1553) were used in the present study.
Details on origin, biofilm producing abilities, presence of
ISMpa1, nsGPL- and ssGPL genes were described by
Johansen et al. [12], and are summarised in Table 1. The
human isolates were from a strain collection at the The
Norwegian Institute of Public Health. All isolates were
grown in Middlebrook 7H9 (BD Diagnostics, Sparks
MD) w/OADC (BD Diagnostics), 1% Tween 80 and 10%
glycerol under agitation for two weeks before aliquotswere stored at −70°C in an equivalent medium contain-
ing 10% glycerol. The concentration of bacteria in the
stock suspensions was determined by colony forming
unit (CFU) counts. Bacterial inocula for the gene expres-
sion assay were prepared from seven days subcultures
grown on plates of Middlebrook 7H10 (BD Diagnostics)
with 10% OADC (BD Diagnostics) at 37°C. To adjust the
number of bacteria in the inoculum, hsp65 real-time
PCR [13] was performed on serial dilutions in HBSS
(Invitrogen, Oslo, Norway) of a suspension adjusted to
McFarland standard 2.0, homogenised through a 23 G
needle to minimise clumping.
Cell culture
Peripheral blood mononuclear cells (PBMCs) were iso-
lated from buffy coat drawn from healthy human blood
donors. The material was commercially obtained from a
blood donation centre, and the study was approved by
the Regional Committee for Medical Research Ethics,
South-East Norway. Fifty mL buffy coat was diluted 1:1
with RPMI 1640 (Sigma-Aldrich, Oslo, Norway) with
1% L-glutamine (Sigma-Aldrich). PBMCs were harvested
by density gradient centrifugation with Lymphoprep
(Medinor, Bryn, Norway) and resuspended in PBS with
0.5% BSA and 2 mM EDTA at pH 7.2. Isolation of CD14+
cells was performed using CD14 MACS magnetic beads
(Milteny Biotec, Bergisch Gladbach, Germany) according
to the manufacturer’s instructions. The cells were resus-
pended in RPMI 1640 with 1% L-glutamine supplemented
with 10% human serum to the desired concentration of
the respective infection assay, added to the appropriate
Costar® cell culture plates (Sigma-Aldrich) and incubated
at 37°C with 5% CO2. The CD14+ cells were incubated
overnight before used in the uptake and replication assays
and allowed to mature into macrophages by incubation
for five days before used in the gene expression study.
Uptake and intracellular replication
Uptake and intracellular replication of the six M. avium
isolates in human blood derived CD14+ cells were assessed.
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(4 × 105 cells/mL, 125 μl per well), which in our hands gave
a stable monolayer for most donors. Each isolate was tested
in triplicates at an MOI of 5:1. The cells were washed twice
with pre-warmed medium to remove extracellular bacteria
before the quantification of intracellular bacteria was per-
formed. Intracellular uptake of the bacterial isolates was
assayed after three, six, 12 and 24 hours in cells from three
donors.
Intracellular replication of the same isolates was assayed
in six other donors, following the protocol described above.
Based on the results from the uptake studies, CD14+ cells
were incubated with the bacterial isolates for six hours.
After removal of extracellular bacteria, fresh medium was
added and the cells were incubated further. Cell lysates
were harvested at six hours, and after one, four and seven
days of infection.
Quantitation of bacteria and cells
Numbers of intracellular bacteria and cells was deter-
mined by enumeration of mycobacterial and human ge-
nomes in cell lysates. Replication of bacterial isolates in
the supernatant had been tested and found insignificant.
Lysis of cells was achieved through adding milliQ water
to the wells. After 30 minutes, lysates were transferred
into 2 mL O-ring vials (Biospec products, Techtumlab,
Umeå, Sweden) containing 200 μL silica beads (Biospec
products) and stored at −20°C. Lysates from triplicate
wells were pooled. After completing all sampling, ly-
sates were thawed and inactivated at 100°C for 30 min,
prior to mechanical disruption using the MiniBead-
Beater (Techtumlab) for 45 sec.
Enumeration of mycobacteria and cells was achieved
by performing a duplex real time PCR of a 103 bp long
segment of the mycobacterial hsp65 gene and a 150 bp
long segment of the human β-globin gene on the lysates,
as described by Salte et al. [13]. Briefly, the segment of the
mycobacterial gene hsp65 (GroEl2) was amplified using
the primers MycoFP1 (5′CGAGGCGATGGACAAGGT-
3′) and TB 12 (5′CTTGTCGAACCGCATACCCT-3′),
and the VIC tagged TaqMan-MGB probe MycoPr1 (5′-
AACGAGGGCGTCACCGTCG-3′) [14]. The segment of
the human β-globin gene was amplified by using the
primers BG-F (5′-TGCCTATCAGAAAGTGGTGGCT-
3′) and BG-R (5′-GCTCAAGGCCCTTCATAATATCC-
3′), and the FAM tagged TaqMan-MGB probe BG-TAQ
(5′-TGGCTAATGCCCTGGCCCACAA-3′) [13,15]. Dilu-
tions of known concentrations of commercially available
mycobacterial DNA (ATCC-19015D-5, LGC Standards,
Middlesex, UK) and human DNA (Applied Biosystems,
Foster City, CA, USA) were run together with the samples
and used to create standard curves. The conversion of the
known amount of standard DNA to number of bacterial
and human genomes were described by Salte et al. [13], aswell as the validation of the number of mycobacterial tar-
gets against CFU counts. Total volume of each reaction
mixture was 20 μl, consisting of 8 μl lysate, 10 μl Quanti-
tect® mastermix (Quiagen, West Sussex, UK) and 1 μl of a
primer/probe mix for each target, with a stock concentra-
tion of 8 μM for each primer and 4 μM for the probe,
resulting in a final primer- and probe concentration of
0.4 μM and 0.2 μM, respectively. Samples and standard
DNA dilutions were run on a Stratagene Mx3005P MxPro
v 4.10 (Stratagene, La Jolla, CA, USA) and data analysed by
the Stratagene MxPro v 4.10 software (Stratagene) with the
following thermal cycling conditions: 95°C for 15 min,
followed by 40 cycles of 95°C for 1 min and 60°C for 1 min.
Gene expression profiling
Isolates Mah VI101, Mah 1655 and Maa 1794, were
used to infect macrophages for gene expression analysis.
CD14+ cells were obtained as described above and
allowed to mature into macrophages by incubation for
five days in duplicate wells (6 well plates, 1 × 106 cells/
mL, 2 ml/well). The cells were then infected with the
three isolates at a MOI of 10:1 for four hours. Total
RNA was isolated of the adherent macrophages using
the RNeasy Mini Kit® (Qiagen, Hilden, Germany), fol-
lowing the manufacturer’s instructions. RNA from the
different donors within each assay was pooled per bac-
terial isolate. The first assay was performed in macro-
phages from three donors and subsequently repeated
twice in two new donors per assay. The quality and
integrity of RNA was confirmed by Agilent 2100 Bioana-
lyzer (Agilent Technologies) and Nanodrop™ (Thermo
Fisher Scientific, Wilmington, DE, USA). Gene expres-
sion levels were profiled using Illumina HumanHT-12
Expression Bead Chip (Illumina Inc., San Diego, CA, USA).
The gene expression data was exported from Illumina’s
GenomeStudio software package without background
subtraction or normalization. The raw data was prepro-
cessed in the R language and environment for statistical
computing [16] employing the normexp by control
(neqc) algorithm [17]. Probes that were not significantly
expressed above background (detection p-value < 0.01
in at least one sample) were filtered out of the analysis.
Differentially expressed genes were identified employing
Bayesian/moderated t-statistics with False Discovery
Rate (FDR) control for multiple testing [18]. Differen-
tially expressed genes were identified at FDR < 0.05. The
raw microarray data have been made publicly available
in the Array Express repository (http://www.ebi.ac.uk/
arrayexpress/experiments/E-MTAB-1101/).
Bioinformatics
Biological functions enriched in the differentially expressed
genes were identified using modular enrichment analysis
with DAVID (Database for Annotation, Visualization and
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were considered statistically significant. Biological path-
ways enriched in the data were identified using IPA soft-
ware (Ingenuity Systems, Redwood City, CA). Upstream
regulator analysis was performed in IPA software to
infer the putative pathways that give rise to the ob-
served gene expression changes. Molecular interaction
networks were reconstructed from the differentially
expressed genes in IPA software using mechanistic data
from prior studies [21]. In this analysis differentially
expressed genes were defined at FDR < 0.01.Protein analysis
CD14+ cells were isolated and matured as described above
for gene expression studies. Cell lawns were infected at an
MOI of 5:1 for 24 hours with Maa 1794, Mah VI101 and
Mah 1655. Supernatants were removed for cytokine pro-
filing, and subsequently the adherent cells were washed
twice in PBS and collected with a cell scraper in 100 μl of
1x SDS Sample Buffer for immunoblotting. All samples


















































Proteins were separated by horizontal SDS-PAGE with
precast gradient ExcelGel™ SDS Gradient 8 – 18% (GE
Healthcare Life Sciences, Uppsala, Sweden) and ExcelGel™
SDS Buffer strips (GE Healthcare) in a Multiphor™ II 2117
(GE Healthcare), prior to diffusion blotting onto nitro-
cellulose membranes with pore size 0.2 μm (Schleicher &
Schuell, Dassel Germany) [22]. Proteins remaining
within the gel were visualized by Coomassie brilliant
blue staining. Membranes were blocked with PBS with
2% BSA and incubated over night with primary anti-
bodies (Cell Signalling Technology, Danvers, MA) rec-
ognizing the following selected proteins involved in
apoptosis: Cleaved caspase-3 (Asp175), cleaved caspase-8
(Asp391), cleaved caspase-9 (Asp315), cleaved caspase-9
(Asp330), Bcl-2, Phospho-Bcl-2 (Ser70). Detection of
bound antibodies was performed by incubaction with
ECL™ Anti-rabbit IgG, Horseradish peroxidise labelled
linked F(ab’)2 fragment from donkey (GE Healthcare) and
visualization by Immun-Star™ WesternC™ Kit (Bio-Rad,
Hercules, CA).0
100 000




Figure 1 Uptake of six clinical isolates of Mycobacterium avium
in human CD14+ cells. Cells were inoculated for three, six, 12 and
24 hours. Numbers represent the mean values from three donors,
showing the ratio of numbers of mycobacterial to human genomes
(A) and absolute numbers of mycobacteria per well (B), measured
by real-time PCR of single copy genes in cell lysates.Cytokine profiling
The concentration of TNF-α, IL-23(p19), IL-10, IL-8 and
IL-6 was measured in supernatants by using Bio-Plex™
Cytokine Assay (Bio-Rad) within the Bio-Plex suspension
array system (Bio-Rad), following the manufacturer’s in-
structions. Differences between isolates were tested for sig-
nificance using the Wilcoxon matched pairs signed-rank
test, considering p-values ≤ 0.05 significant.Results
Uptake and intracellular replication
All the isolates were taken up by the CD14+ cells, and
intracellular bacteria were detected after 3 hours (Figure 1).
Maa 1553, Mah H38 and Maa 1794 appeared to be taken
up to a greater extent, while the Mah isolate VI101 showed
the lowest degree of uptake in macrophages. Between six
and 12 hours of infection some of the isolates showed an
exponential increase in the number of intracellular bacteria,
suggesting the event of onset of intracellular replication. Six
hours was therefore chosen as the time between inocula-
tion and removal of extracellular bacteria for the subse-
quent study of intracellular replication over time. At this
point in time VI101 had significantly (p < 0.05) lower num-
bers of intracellular bacteria compared to the other isolates
except for Mah H1, while no significant difference were ob-
served between the other isolates using the paired t-test.
Intracellular growth was only observed for the two
Maa isolates. There was a significant increase in the ra-
tio of mycobacteria to human genomes at day four for
isolate Maa 1794 (p = 0.04) and at day 7 for Maa 1794
(p = 0.01) and Maa 1553 (p = 0.02) and in absolute
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day 7 using the paired t-test (Figure 2). The remaining
isolates, which were all Mah, did not show significant in-
crease in intracellular numbers throughout the duration
of infection, however the count of intracellular bacteria
was quite stable, indicating that the bacteria were able to
persist within the macrophages.
Enumeration of both cells and intracellular mycobac-
teria was performed by real-time PCR of single-copy
genes. This method does not distinguish between viable
and non-viable bacteria and cells, but it has the advan-
tage that the number of bacteria is not influenced by the
degree of clumping which varies between Maa and
Mah. Furthermore it enabled the measurement of the
number of intracellular bacteria per cell in addition to
absolute counts of bacteria. Some degree of cell death
























































Figure 2 Intracellular replication of six clinical isolates of
Mycobacterium avium in human CD14+ cells. Sampling was
performed after six hours of inoculation with added bacteria, then
one, four and seven days after removal of extracellular bacteria.
Numbers represent the mean values from six donors, showing the
ratio of numbers of mycobacterial to human genomes (A) and
absolute numbers of mycobacteria per well (B), measured by real-time
PCR of single copy genes in cell lysates. There was a significant increase
in the ratio of mycobacteria at day four for isolate Maa 1794 (p = 0.04)
and at day 7 for Maa1794 (p = 0.01) and Maa 1553 (p = 0.02) and in
absolute numbers of bacteria for isolate Maa 1794 (p = 0.01) at day 7
using the paired t-test.and non-infected cells, and varied considerably between
donors. Similar results were observed whether absolute
numbers of bacteria or the bacteria per cell ratio were
used, however the difference in cell death between do-
nors may explain why the absolute counts of bacteria
only reached a significant level of p < 0.05 for Maa 1794
at day 7, while the ratio was significant for both Maa
isolates at day 7 and for Maa 1794 at day 4.
Gene expression analysis and bioinformatics
Based on the results from the initial replication assays,
three isolates were selected for gene expression studies
in macrophages. Maa 1794, which replicated intracel-
lularly, and Mah VI101, which only persisted within
cells, were selected, in addition to Mah 1655, which, as
opposed to the other two isolates, contains the IS elem-
ent ISMpa1 and belong to an RFLP type that has been
demonstrated to be particularly virulent in pigs [23,24].
The Illumina® HumanHT-12 v3 Expression Bead al-
lows whole-genome expression analysis of 12 samples
on the same chip, each array targeting genomewide with
more than 48,000 probes. Of the 14,581 probe sets with
signal intensity above background, 2,766 probe sets were
differentially expressed (FDR < 0.05) in the cells infected
with M. avium (1,229 up-regulated, 1,537 down-regulated),
regardless of the individual isolate, compared to uninfected
control cells (Additional file 1: Table S1). The largest
response was induced by Maa 1794 where 2,439 probe
sets (representing 2,147 unique genes) were differentially
expressed. Of these probe sets, 1,077 were up-regulated,
and 1,362 were down-regulated. Mah VI101 modulated
expression of 1,520 probe sets (810 up-regulated, 710
down-regulated) representing 1,348 unique genes. In com-
parison, Mah 1665 altered the expression of only 341
probe sets (239 up-regulated 102 down-regulated) repre-
senting 298 unique genes. A large overlap was observed in
the responses elicited by the three isolates (Figure 3). There
were virtually no genes (5 transcripts only) that were
uniquely modulated by Isolate Mah 1655. In contrast,
hundreds of genes were uniquely differentially expressed in
response to infection with Maa 1794 and MahVI101.
Bioinformatics analyses demonstrated that the major
biological functions up-regulated in response to the three
isolates were apoptosis, inflammatory response, cytokine/
chemokine activity, signal transduction, cell-proliferation
and regulation of T-cell activation (Table 2). Biological
pathways up-regulated in the responses were related to
apoptosis and innate immunity and cytokine signaling
(Table 3). In addition, communication pathways between
innate and adaptive immune responses and IL-17 signaling
were up-regulated. Upstream regulator analysis was per-
formed to infer the putative molecular mechanisms that
give rise to the observed gene expression changes, and is
illustrated in Table 4. This analysis revealed major roles for
Table 2 Analysis of biological functions induced infection
of human monocyte-derived macrophages with M. avium
isolates

































Induction of apoptosis 6.6
Cytokine/chemokine activity 5.9






















Induction of apoptosis 13.0













Regulation of protein cytokine
secretion
4.9
Regulation of phosphorylation 4.3
The analysis was done using the Database for Annotation, Visualization and
Integrated Discovery (DAVID). An Enrichment score > 1.3 was considered
statistically significant.
Figure 3 Numbers of differentially expressed genes in human
macrophages infected with different isolates of Mycobacterium
avium. The Venn diagrams of numbers of up-regulated (A) and down-
regulated (B) genes show unique and common differential expression
of transcripts in human macrophages in response to four hours of
incubation by three different isolates of Mycobacterium avium. Maa
1794 is an intracellularly replicating isolate of M. avium subsp.
avium, whereas Mah VI101 and Mah 1655 are isolates of M. avium
subsp. hominissuis that only invade and persist within cells.
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the responses. Altogether these analyses revealed a strong
overlap between the impacts of all the three isolates.
To identify the putative molecular mechanisms that
are regulating the responses, we constructed molecular
interaction networks for each isolate using mechanistic
findings from previous studies. This analysis showed
that Maa 1794 induced the largest gene network in hu-
man macrophages, followed by Mah VI101, then by
Mah 1655 (Figure 4). The networks were organized
around a series of hyper-connected hubs, and the most
important hubs (based on number of interactions) are
listed in the Table 5. Notably, the network connectivity
patterns were dominated by TNF, IL-1B, IL-6, NFkB1,
Table 3 Canonical pathway analyses
Up-regulated p-value
Mah VI101 compared to uninfected TNFR2 signaling 6.3E-14
Role of macrophages, fibroblasts and endothelial cells in rheumatoid arthritis 5.0E-11
Death receptor signaling 5.0E-11
Regulation of cytokine production in macrophages and Th cells by IL-17A and IL-17 F 6.3E-11
Role of IL-17A in arthritis 1.9E-10
TNFR1 signaling 2.8E-10
TREM1 signaling 7.6E-10
Regulation of cytokine production in intestinal epithelial cells by IL-17A and IL-17 F 1.4E-09
Hepatic fibrosis/Hepatic stellate cell activation 1.7E-09
IL-6 signaling 1.9E-09
Mah 1655 compared to uninfected TNFR2 signaling 6.3E-12
4-1BB signaling in T lymphocytes 7.2E-10
TNFR1 signaling 1.1E-09
Small cell lung cancer signaling 2.9E-09
Role of IL-17A in arthritis 4.0E-09
Death receptor signaling 7.6E-09
Induction of apoptosis by HIV1 8.9E-09
iNOS signaling 1.4E-08
Type I diabetes mellitus signaling 1.5E-08
Regulation of cytokine production in macrophages and Th cells by IL-17A and IL-17 F 1.9E-08
Maa1794 compared to uninfected Death receptor signaling 1.0E-13
TNFR2 signaling 1.0E-12
Role of macrophages, fibroblasts and endothelial cells in rheumatoid arthritis 2.5E-11
Small cell lung cancer signaling 6.3E-11
Role of IL-17 F in allergic inflammatory airway diseases 1.4E-10
TWEAK signaling 3.0E-10
Role of IL-17A in arthritis 3.7E-10
TNFR1 signaling 4.1E-10
Regulation of cytokine production in macrophages and Th cells by IL-17A and IL-17 F 5.1E-10
IL-17A Signaling in fibroblasts 7.1E-10
Down regulated p-value
Mah VI101 compared to uninfected Role of CHK proteins in cell cycle checkpoint control 1.2E-04
Tetrapyrrole biosynthesis II 1.9E-04
Galactose degradation I (Leloir pathway) 1.9E-04
Mismatch repair in Eukaryotes 7.8E-04
Heparan sulfate biosynthesis 8.1E-04
Role of BRCA1 in DNA damage response 1.2E-03
Heme biosynthesis II 1.5E-03
Glycine betaine degradation 2.1E-03
Coenzyme A biosynthesis 2.2E-03
L-serine degradation 2.2E-03
Mah 1655 compared to uninfected Colorectal cancer metastasis signaling 4.4E-04
Hereditary breast cancer signaling 1.3E-03
Role of BRCA1 in DNA damage response 1.9E-03
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Table 3 Canonical pathway analyses (Continued)
IL-12 signaling and production in macrophages 2.2E-03
Sulfite oxidation IV 4.2E-03
Antiproliferative role of TOB in T cell signaling 5.1E-03
Dendritic cell maturation 6.0E-03
Role of NFAT in cardiac hypertrophy 6.5E-03
HMGB1 signaling 6.6E-03
Superpathway of inositol phosphate compounds 6.9E-03
Maa1794 compared to uninfected Mismatch repair in Eukaryotes 6.3E-07
Role of BRCA1 in DNA damage response 2.9E-06
CHK proteins in cell cycle checkpoint control 5.6E-06
CTLA4 signaling in cytotoxic T lymphocytes 7.9E-06
Hereditary breast cancer signaling 1.5E-05
Growth hormone signaling 1.7E-05
Molecular mechanisms of cancer 1.7E-05
ERK5 signaling 2.7E-05
Production of NO amd ROS in macrophages 3.8E-05
B cell receptor signaling 1.3E-04
Pathways induced by infection of human monocyte-derived macrophages with M. avium isolates.
The analysis was done in Ingenuity Systems software.
The ten top pathways are shown.
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ways were also highlighted by the upstream regulator
analysis.
Differential gene expression elicited by Maa 1794, Mah
VI101 and Mah 1655
At FDR < 0.05, no significant differences were observed
between cells infected with Maa 1794 and Mah VI101,
while only two genes (IL6, GPR109A) were upregulated in
Maa 1794 compared to Mah 1655 and one gene (IL-6)
was upregulated in MahVI101 compared to Mah 1655.
Protein analysis
Gene expression analysis pointed to apoptosis and
immune response as two major biological functions
upregulated in response to all three M. avium isolates,
albeit at lower levels in Mah 1655 compared to Maa
1794 and Mah VI101. We thus attempted to look at
proteins involved in apoptosis by western blot and
cytokine by a multiplex assay. However, differences be-
tween the isolates with regards to apoptotic proteins
were not detected, probably due to the lower sensitiv-
ity in this assay compared to the microarray analyses
(data not shown).
Macrophages infected with all three isolates consist-
ently produced more IL-10, IL-23 and TNF-α than unin-
fected controls (Figure 5). The production of IL-6 andIL-8 in uninfected cells was often high, and in some do-
nors infection led to a decrease in cytokine production.
The decrease in cytokine production was particularly
evident for IL-8 after infection with Maa 1794, to a
lesser extent by infection with Mah 1655 and rarely by
Mah VI101 (Figure 5). There was a large donor to donor
variation in the amount of cytokines produced, and this
variation surpassed the difference induced by the iso-
lates. Nevertheless, Mah VI101 consistently induced
more IL-8, IL-23 and TNF-α than Maa 1794 (p < 0.05)
and more IL-23 than Mah 1655 (p < 0.05).
Discussion
The present study describes the uptake and intracellular
growth of Maa and Mah isolates in human monocytes,
and characterises genome-wide transcriptional responses
elicited by these isolates in macrophages. Mycobacterium
avium isolates of different genotypic characteristics were
all able to enter and persist within human primary
monocytes. Intracellular replication was only seen by
Maa suggesting that the differences in the ability to sur-
vive and replicate in macrophages cannot explain why
humans are more often infected with Mah. The gene ex-
pression program induced by infection with Maa and
Mah isolates was broadly comparable in terms of the
biological functions, pathways, and gene networks that
were perturbed. However, the degree of perturbation











































Genes predicted to act as up-stream regulators for the observed responses
after infection of human monocyte-derived macrophages with M. avium isolates.
The analysis was done in Ingenuity Systems software. Responses to chemicals/
drugs are excluded. The ten top genes are shown.
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http://www.biomedcentral.com/1471-2164/15/58varied considerably. The different level of expression led
to an apparent discrepancy in the number of unique
genes induced by the various isolates and the lack of dif-
ferences when comparing the isolates with each other.
Many of the genes significantly induced by Maa1794
were also induced at a lower level by the other isolates
(Additional file 2: Figure S1). This intermediate expres-
sion was neither significantly different from uninfectedcells nor from Maa1794. A larger samples size might
have given more significant differences between the iso-
lates since large donor to donor variation is present
when using primary cell lines.
In general, responses to Maa1794 were excessive, and
were characterized by increased expression of genes
downstream of type I and II interferon signaling. Further
studies will be required to determine if variations in
these pathways account for the exaggerated responses
and/or differences in prevalence. Similar pathways were
induced in ruminant monocyte derived macrophages in-
fected with the closely related Mycobacterium avium
subspecies paratuberculosis (Map) [25-27], while a study
using the murine cell line RAW264.7 showed that Maa
and Mah induced higher levels of pro-inflammatory
genes compared to Map [28]. Together with our data,
these studies suggest that similar pathways were induced
by all M. avium subspecies. A direct comparison of the
level of macrophage activation is however challenging
considering the variation in cell cultures and isolates
used in the various studies.
Macrophage activation can be interpreted as an app-
ropriate reaction to an invading pathogen or as a failed
attempt of the mycobacteria to silence the host’s
defences. Maa 1794 and Mah VI101 differed completely
in their ability to replicate within host cells, although
both isolates induced a strong activation of macro-
phages and innate immune responses on the transcrip-
tional level. Analyses on the protein level revealed that
the final synthesis of inflammatory cytokines were
higher in response to Mah VI101 compared to Maa
1794. One could thus argue that the inflammatory re-
sponse was sufficient to limit growth of Mah VI101, but
not Maa 1794. The complexity of the outcome of an in-
fection, and in vitro culture, was illustrated by the fact
that despite a low activation of the innate immune re-
sponse Mah 1655 did not proliferate intracellularly. The
microarray data provided no clear explanation to the
lower level of inflammatory cytokines induced by Maa
1794 on the protein level compared to Mah VI101.
However, regulation of inflammation on the post-
transcriptional level has been demonstrated to be im-
portant [29], and a down-regulation of immune re-
sponses to avoid immunopathology can occur in
chronic infections. The presence of unidentified virulence
factors in Maa 1794 more actively shutting down the in-
nate responses cannot be excluded. The genomes of the
three isolates did for instance differ in the presence of
GPL genes, and the involvement of GPLs in M. avium
colony morphology and of ssGPLs in pathogenicity is in-
creasingly recognised [30-32].
The induction of pro-apoptotic genes, such as
RIPK2, BID and tBID was seen after infection with all
three isolates, however apoptotic pathways were
Figure 4 Gene networks triggered in human macrophages infected with different isolates of Mycobacterium avium. Cells have been incubated with M. avium subsp. avium 1794 (A), M.
avium subsp. hominissuis VI101 (B) and M. avium subsp. hominissuis 1655 (C) for four hours. Blue hubs indicate up-regulation, yellow indicate down-regulation of the respective gene. The size of
the gene name reflects the number of links to other genes in the network, and genes with < 5 genes are minimized. For this analysis the number of genes was reduced, in order to comply with




















Table 5 Top 20 hub genes and number of connections induced by infection of human monocyte-derived macrophages
with M. avium isolates
Mah 1655 Mah V101 Maa 1794
Gene ID No. of interactions Gene ID No. of interactions Gene ID No. of interactions
TNF 61 TNF 178 TNF 219
IL1B 43 IL6 117 IL6 141
IL6 38 IL1B 113 IL1B 127
NFKBIA 34 NFKBIA 81 NFKBIA 93
NFKB1 27 IL10 80 FOS 88
IL1A 22 NFKB1 70 NFKB1 76
PTGS2 19 FOS 69 CSF2 66
NFKB2 18 CSF2 59 ILIA 63
CXCL2 18 ILIA 58 BCL2 59
CCL5 18 JUN 57 OSM 59
OSM 17 CD40 53 CD40 58
TNFAIP3 14 PTGS2 52 PTGS2 56
CCL3L1 14 Rb1 50 SRC 55
LIF 14 BCL2 47 RB1 50
CCL20 14 OSM 47 IL15 50
REL 13 VEGFA 46 CXCL2 45
SOD2 13 SRC 43 CCL5 42
NFKBIB 11 CCL5 42 PIK3R1 42
CCL3 11 CXCL2 42 CEBPA 41
TRAF1 10 NFKB2 38 TICAM1 41
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http://www.biomedcentral.com/1471-2164/15/58affected to a lesser degree by Mah 1655 than by Maa
1794 and Mah VI101. The correlation between apop-
tosis and virulence of mycobacterial strains is debated.
Inhibition of apoptosis has been described as a virulence
factor in mycobacteria [33-35], but it has also been
suggested that M. avium can use apoptosis of macro-
phages as a tool for spreading [36]. One of the other more
pronounced differences between the isolates was the
increased expression of genes involved in activation of T
cells like CD25, CD40, CD274 and IL23 in Maa 1794 and
Mah VI101. CD25, CD40 and CD274 are transmembrane
surface proteins involved in activation of macrophages
and T cells upon binding, while IL-23 is essential for the
persistence and function of Th17 cells [37,38]. These
findings suggest that differential activation of apoptotic
pathways and/or activation of T cells may occur in
humans after infection with the different isolates. The
lower activation of macrophages by Mah 1655 may be a
useful strategy to avoid the induction of an adaptive
immune response in the host. This isolate was included
because it harbours ISMpa1 and has a similar IS1245
RFLP pattern to strains shown to be associated with
virulence [24,39]. Further studies, including experimental
infection models, could provide an answer to whether the“silencing approach” of Mah 1655 might be the most
successful strategy.
Other possible explanations for the low prevalence of
Maa observed in the human population, and also in
pigs, include the lack of exposure or a reduced ability to
cross the human intestinal barrier. In the Norwegian pig
population only Mah has been isolated [24], but the
virulence of Maa in pigs has been demonstrated by
others [40], and previous research demonstrated that
Maa 1794 and Mah VI101 were equally able to infect
piglets [41]. It thus appears that a lack of exposure is the
most likely explanation for the difference in prevalence
in pigs. The virulence of Maa has also been demon-
strated in mice [42]. Although the study of Pedrosa et al.
was performed prior to the division of M. avium into
subspecies, one could assume that the bird isolates used
in the older studies are equivalent with Maa, and the
human isolates with Mah. The virulence of M. avium
subspecies in humans can obviously not be determined
in vivo. However, altogether the studies in human pri-
mary cell lines and infection studies in other species,
suggest that different exposure to Mah and Maa in
humans is a plausible explanation for the difference in
prevalence.
Figure 5 Cytokine expression from primary monocyte-derived macrophages. CD14+ cells were obtained from six donors and allowed to
mature into macrophages by incubation for five days. The cells were then infected with the three isolates, Maa 1794, Mah 1655 and Mah VI101,
at a MOI of 10:1 for 24 hours or left uninfected (neg). The supernatant was removed and assessed for IL-6, IL-8, IL-10, IL-23 and TNF-α by the
Bio-plex assay. The six donors are represented with individual symbols. Each point is the median of triplicate wells. The horizontal line represents
the mean response of the six donors. Mah VI101, consistently produced more IL-8, IL-23 and TNF-α than Maa 1794 and more IL-23 than Mah 1655. The
difference was significant (p < 0.05) using the non-parametric Wilcoxon signed rank test.
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In conclusion, our findings demonstrate that the ability
to replicate in macrophages cannot explain the difference
in prevalence of the two subspecies in humans. Genome-
wide expression profiling studies further showed that simi-
lar biological pathways and networks were elicited by the
two subspecies, although responses to the Maa subspecies
were exaggerated.
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